(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ Composite: INO) jumped 8.49% to $8.43 at 10:31 EST on Monday, after two consecutive sessions in a row of losses. NASDAQ Composite is rising 1.03% to $14,865.94, after two successive sessions in a row of gains. This seems, up to now, an all-around positive trend exchanging session today.
Inovio Pharmaceuticals’s last close was $7.77, 59.11% below its 52-week high of $19.00.
Today’s last reported volume for Inovio Pharmaceuticals is 864780 which is 82.71% below its average volume of 5002962.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is 2.2% for the present quarter and 4688.1% for the next. The company’s growth estimates for the current quarter is 69.9% and a drop 318.2% for the next.
Inovio Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 72%, now sitting on 6.46M for the twelve trailing months.
Inovio Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a positive 0.08%, a negative 0.44%, and a positive 2.96%, respectively.
Inovio Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.89% (last week), 2.92% (last month), and 2.96% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Inovio Pharmaceuticals’s stock is considered to be overbought (>=80).
Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value
Inovio Pharmaceuticals’s stock is valued at $8.43 at 10:31 EST, way below its 52-week high of $19.00 and way above its 52-week low of $5.81.
Inovio Pharmaceuticals’s Moving Average
Inovio Pharmaceuticals’s value is below its 50-day moving average of $8.67 and below its 200-day moving average of $9.20.
More news about Inovio Pharmaceuticals (INO).